For the second year in a row, the Berlin Conference addresses the AMR market and its challenges with a particular focus on the challenges of small and medium-sized enterprises (SMEs). The one-day event aims at bringing together people from science and business, investors and policy makers, funding bodies and venture capitalists, startups and health economics experts, the public and private sector, to build a discussion platform for all stakeholders.
BIOCOM AG and the BEAM Alliance, representing biopharmaceutical companies from Europe innovating in antimicrobial resistance research, invite to attend the following event:
Novel Antimicrobials & AMR Diagnostics
11th Berlin Conference in Life Sciences
Fraunhofer-Forum Berlin, 2nd March 2018